Sanjay Shukla
President and CEO at aTyr Pharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: aTyr Pharma Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
aTyr Pharma Inc. May 22, 202499.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | aTyr Pharma Inc. | Open-market sale | −3,745 | $0.98 | $3,670 |
| Feb 3, 2026 | aTyr Pharma Inc. | Option exercise | +10,375 | — | — |
| Feb 3, 2025 | aTyr Pharma Inc. | Option exercise | +10,375 | — | — |
| May 31, 2024 | aTyr Pharma Inc. | Open-market purchase | +20,000 | $1.81 | $36,200 |
| Feb 5, 2024 | aTyr Pharma Inc. | Option exercise | +10,375 | — | — |
| Dec 12, 2023 | aTyr Pharma Inc. | Open-market purchase | +12,000 | $1.18 | $14,160 |
| Dec 11, 2023 | aTyr Pharma Inc. | Open-market purchase | +3,000 | $1.17 | $3,510 |
| Nov 13, 2023 | aTyr Pharma Inc. | Open-market purchase | +13,578 | $1.11 | $15,072 |
| Nov 10, 2023 | aTyr Pharma Inc. | Open-market purchase | +1,422 | $1.14 | $1,621 |
| Jul 28, 2023 | aTyr Pharma Inc. | Open-market purchase | +15,000 | $2.01 | $30,150 |
| Feb 3, 2023 | aTyr Pharma Inc. | Option exercise | +10,375 | — | — |
Questions about Sanjay Shukla
What boards is Sanjay Shukla on?
Sanjay Shukla sits on the board of aTyr Pharma Inc.
What company is Sanjay Shukla the CEO of?
Sanjay Shukla is President and CEO of aTyr Pharma Inc.
How long has Sanjay Shukla served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.